Table 5 |
||||||
| Effect of the multidisciplinary structured lifestyle intervention on estimated 10-year risk of cardiovascular events, general health and quality of life among patients with stable cardiovascular disease compared with usual care at baseline, and at 3 and 6 months | ||||||
| Secondary outcome measures | Baseline | 3 months | 6-months | |||
| Intervention n = 71 | Control n = 75 | Intergroup differencesaB(95% CI) | p | Intergroup differencesaB(95% CI) | p | |
| 10-year risk cardiovascular eventa | ||||||
| Coronary heart disease | 37.3 (20.3) | 33.8 (18.8) | −0.6 (−3.4/2.2) | 0.67 | −0.6 (−4.3/3.1) | 0.75 |
| Myocardial infarction | 18.9 (13.9) | 17.1 (11.6) | −1.1 (−3.0/0.9) | 0.29 | −0.8 (−3.5/1.8) | 0.53 |
| Cerebrovascular accident | 8.2 (8.0) | 7.3 (6.1) | −0.5 (−1.5/0.4) | 0.26 | −0.3 (−1.4/0.9) | 0.66 |
| Total mortality | 35.0 (18.1) | 34.1 (17.1) | 0.2 (−2.6/3.0) | 0.89 | 1.1 (−1.6/3.8) | 0.43 |
| General health and quality of life | ||||||
| SF-36 MCS | 52.9 (9.8) | 52.2 (11.0) | 0.6 (−1.6/2.9) | 0.58 | −0.8 (−3.1/1.5) | 0.50 |
| PCS | 39.6 (10.6) | 42.2 (9.5) | 1.6 (−1.0/4.1) | 0.23 | 1.0 (−1.7/3.7) | 0.47 |
| MacNew b | 5.3 (0.8) | 5.2 (0.9) | 0.06 (−0.1/0.3) | 0.56 | 0.04 (−0.2/0.2) | 0.69 |
| Vascuqol c | 4.8 (1.4) | 5.6 (0.9) | −0.09 (−0.9/0.7) | 0.81 | −0.2 (−1.7/1.3) | 0.78 |
Numbers are mean (SD) unless stated otherwise; 95% CI= 95% confidence interval; MCS=, norm-based Mental Composite Score; PCS=norm-based Physical Composite Score; aUsing the PRECARD®-riskscore24; btotal score only among cardiology patients; ctotal score only among vascular patients.
IJzelenberg et al. BMC Cardiovascular Disorders 2012 12:71 doi:10.1186/1471-2261-12-71
